Immuron enrols first patients in Campylobacter Challenge clinical study

The US Naval Medical Research Command (NMRC) has initiated the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic...

Related Keywords

United States ,Kawsar Talaat ,Immunization Research ,Johns Hopkins University ,Us Naval Medical Research Command ,Immuron Ltd ,Medical Research Command ,Enterotoxigenic Escherichia ,Principal Investigator Dr Kawsar Talaat ,Inpatient Unit ,Medical Campus ,